Clinical studies have demonstrated substantial weight reduction in participants using Tirzepatide, which opens up exciting possibilities for its application as an anti-obesity treatment
So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
Anyone with kidney problems, heart disease, or who takes specific medications should consult their healthcare provider prior to starting anything
Smoking and Other Risk Factors in Type 2 Diabetes
If youve been diagnosed with gastroparesis from Ozempic or experienced gallbladder removal after Wegovy use, you may have grounds for a GLP-1 drug lawsuit
59 Band Glute Kickbacks: Works glutes